PACB

Pacific Biosciences Of California
$1.27
−$0.02 (−1.55%)Sep 10, 2026
0.8PoorMoatMint rating

MoatMint rates Pacific Biosciences Of California (PACB) 0.8 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 3.1 out of 10.

Key metrics

The numbers that frame PACB today
Market cap
$394.76M
P/E (TTM)
-3.0
EV / FCF
-14.2
Gross margin
36.4%
EV / Sales
6.5
ROIC
-12%
Div yield
0%
52wk Low
$1.07
52wk High
$2.73

PACB stock rating

How PACB scores on quality, value, growth, momentum and financial health
0.8out of 10
Low overallNeutral business, expensive price
Quality3.1
Growth1.4
Momentum1.8
Value2.3
Financial Health0.9

Growth

Revenue and earnings trend for PACB
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about PACB
Is Pacific Biosciences Of California a good buy?
No. Pacific Biosciences Of California has weak quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Pacific Biosciences Of California is selling at a very high price.
What is the market capitalization of PACB?
Pacific Biosciences Of California's market capitalization is $394.76M.
What is the P/E ratio for PACB stock?
Pacific Biosciences Of California's current P/E ratio is -3.
What is the 52-week high for PACB stock?
The 52-week high for Pacific Biosciences Of California is $2.73. The current close of $1.27 is 53.5% below that high.
What is the 52-week low for PACB stock?
The 52-week low for Pacific Biosciences Of California is $1.07. The current close of $1.27 is 18.7% above that low.
Does PACB stock pay dividends?
Pacific Biosciences Of California does not currently show a dividend per share in the company data.